Stock Region Penny Picks
Stock Region Penny Picks
Stock Region Penny Picks Newsletter - Monday, September 16th, 2024.
Stock Region Penny Picks Newsletter - Monday, September 16th, 2024
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: This newsletter is for educational purposes only and should not be considered as financial advice. Always conduct your own research or consult with a financial advisor before making investment decisions.
$NCNA - NuCana (NCNA)
NuCana has presented promising data on their NUC-7738 in combination with Pembrolizumab for patients with PD-1 inhibitor refractory and resistant melanoma at the ESMO Congress 2024. This development could potentially enhance the therapeutic options for melanoma patients and boost investor confidence in NuCana’s innovative oncology pipeline.
$ZNTL - Zentalis Pharmaceuticals (ZNTL)
Zentalis Pharmaceuticals announced that the FDA has lifted its partial clinical hold on Azenosertib studies. This is a positive development, allowing the company to proceed with their clinical trials, which may lead to future breakthroughs in cancer treatment and positively impact the stock's performance.
$SLNH - Soluna Holdings (SLNH)
Soluna has signed a term sheet with a leader in renewable energy for a new data center project. This strategic partnership could expand Soluna’s capabilities in renewable energy, potentially driving future growth and offering a competitive edge in the market.
$APVO - Aptevo Therapeutics (APVO)
Aptevo Therapeutics, in collaboration with Alligator Bioscience, reported that 60% of evaluable patients achieved stable disease in their Phase 1 ALG.APV-527 monotherapy trial for solid tumors. This promising result may enhance the therapeutic profile of their oncology pipeline and attract investor interest.
$REE - REE Automotive (REE)
REE Automotive has entered into a global manufacturing agreement with the Motherson Group, along with a strategic investment of $45.35 million led by M&G. This partnership could accelerate REE’s manufacturing capabilities and market penetration, signaling potential growth opportunities.
$KAPA - Kairos Pharma (KAPA)
Kairos Pharma made its IPO debut, opening at $3.75, below the initial pricing of $4, and currently trading at $3.16. Based in Los Angeles, the company is focused on developing oncology therapeutics aimed at reversing cancer drug resistance and immune suppression, which might interest investors looking for innovative biotech opportunities.
$SMSI - Smith Micro Software (SMSI)
Smith Micro Software has withdrawn its recent offering, a move that might affect its short-term financial strategy. Investors may want to monitor the company’s future announcements for further clarity on its financial planning.
Disclaimer: This newsletter is for educational purposes only and should not be considered as financial advice. Always conduct your own research or consult with a financial advisor before making investment decisions.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net